Keynote Speakers


This years conference keynote speakers will be focusing on the future of Healthcare and the changing role of the statistician to account for this.

PSI keynote speaker 1

Dr. Nupur Kohli

Medical Doctor, Advisor Healthcare, Global Speaker, Researcher, Author

In the coming future healthcare will face a big pressure due to the changing demographics of the world.

In this talk Dr. Kohli will highlight the current challenges in the healthcare delivery system and share learnings from global experiences in the current healthcare system. She will also share opportunities, new developments and the impact new implementations will have for the future.

As technology improves every day, new developments are constantly changing the dynamics of the healthcare sector. Can the healthcare sector keep pace? And how are the Netherlands and Europe dealing with the changes?

About this and more Dr. Kohli will talk presenting both from the healthcare providers and healthcare receivers point of view.


  • Winner of the VIVA400 Award for Most Inspiring Woman of the Netherlands 2016 in the category Smart Brains.
  • Winner of one of the 50 most inspiring women in technology the Netherlands, Europe, by Inspiring Fifty Europe.
  • Winner of the TEDx best speaker Award in Delft in 2012.

    Nupur has obtained her M.D. title at the Academic Medical Center in Amsterdam and has studied Fundamentals of Business at Harvard Business School, USA. As an internationally recognized speaker, Nupur has given more than 80 speeches worldwide over the past few years. In 2012 she gave her first TEDx Talk to an audience of 1000 plus in Delft. In 2016 she gave her second TEDx Talk at Nyenrode Business University. She featured on national television, radio and in newspapers in the Netherlands and in more than two dozen other prominent print and online media around the world.
    She worked as a strategic management advisor for healthcare at Ernst and Young and is a community pediatrician.
    Nupur is a trend-spotter in healthcare with a special interest in Europe and Asia. She regularly
    interacts with decision makers in the healthcare Industry. Her other interest is to reduce stress in
    societies and corporates, which influences decision making, productivity and profitability. She has done significant research on stress and productivity and is the author of the book ‘Chill! How to survive stress and improve personal and professional productivity. Symptoms and solutions to
    chronic pressure’.
PSI keynote speaker 2

Steve Ruberg

Distinguished Research Fellow, Enterprise Data and Analytics, Global Statistical Sciences, Eli Lilly & Company

The world is exploding with data, and the application of ‘analytics’ is growing at a commensurate rate. The question remains: “Are we using the right data and are we applying smart analytics?” This talk will explore statistics versus data science and highlight how statisticians in the pharmaceutical industry can reinvent themselves to play a much broader role in their companies than the historical role in clinical development or R&D. It will also the value of statistics beyond data science, and encourage statisticians as well as our profession to insure we communicate our value appropriately.


Steve Ruberg received his B.A. in mathematics from Thomas More College, an M.S. in statistics from Miami University (Ohio) and his Ph.D. in biostatistics from the University of Cincinnati. Steve has spent over 36 years in the pharmaceutical industry, including 17 years at Eli Lilly. During his career, he has served as a statistician and scientific leader in all phases of drug development from discovery through post-marketing. Steve has published widely in statistical and biological/medical journals, and in 1994, he was elected a Fellow of the American Statistical Association.

He has held significant leadership  roles across the industry: Deputy Chair and co-author of ICH-E9 – Statistical Principles for Clinical Trials; chaired the PhRMA Biostatistics and Data Management Committee; helped launch CDISC and served as its first Chairman of the Board; chaired the Board of Governors for The Ohio State University Mathematical Biosciences Institute. In 2008, Steve was appointed by the Secretary of the US Department of Health and Human Services to the Board of Directors of the National eHealth Collaborative. In 2009, Steve was named the Scientific Leader for the newly formed Eli Lilly Advanced Analytics Hub. The positive impact of this group has grown into a corporate endeavor called Enterprise Data and Analytics. In this role, which seeks to foster an analytical mindset and to create novel applications of analytics to drive business value. In 2012, Steve received the Career Achievement Award from the Quantitative Sciences in the Pharmaceutical Industry organization.

Steve’s current statistical interests are in Bayesian statistics for drug development and estimands, and he also enjoys teaching, golf and his many grandchildren.

Website Banner Template

Latest News

Show all news

EventsFuture Events


Biostatistician Project Leader- Early Clinical Development



GlaxoSmithKline is looking for Talented Clinical Statisticians



Senior Biostatistician


Novartis Image

Senior Quantitative Safety Scientist